Full Press Release Details
EQUITY INCENTIVE PLAN
by Shareholders July 17, 2019
4.1 of the OncoCyte Corporation 2018 Equity Incentive Plan is amended to read as follows:
Subject to adjustment in accordance with Section 11, a total of 11,000,000 shares of Common Stock shall be available
for the grant of Awards under the Plan. Any shares of Common Stock granted in connection with Options and Stock Appreciation Rights
shall be counted against this limit as one share for every one Option or Stock Appreciation Right awarded. Any shares of Common
Stock granted in connection with Awards other than Options and Stock Appreciation Rights shall be counted against this limit as
two (2) shares of Common Stock for every one (1) share of Common Stock granted in connection with such Award. During the terms
of the Awards, the Company shall keep available at all times the number of shares of Common Stock required to satisfy such Awards.